The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study
Clinical trial NCT01217463 · COMPLETED
Trial details
- NCT number
- NCT01217463
- Sponsor
- Olympus Biotech Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2012-03-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.